Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash | 1.59 | 0.71 | 0.19 | 0.65 |
Short Term Investments | 1.30 | 0.42 | 7.51 | 6.49 |
Cashand Short Term Investments | 2.89 | 1.12 | 7.70 | 7.14 |
Accounts Receivable- Trade Net | 184.48 | 189.78 | 136.28 | 162.01 |
Total Receivables Net | 199.99 | 199.04 | 136.30 | 162.03 |
Total Inventory | 34.68 | 65.18 | 13.68 | 18.46 |
Other Current Assets Total | 45.04 | 2.80 | 68.64 | 30.74 |
Total Current Assets | 282.60 | 270.61 | 226.32 | 218.38 |
Property/ Plant/ Equipment Total- Net | 14.66 | 13.94 | 14.47 | 14.26 |
Long Term Investments | 1.38 | 0.41 | 0.40 | 0.40 |
Note Receivable- Long Term | 0.71 | 0.78 | 3.98 | - |
Other Long Term Assets Total | 5.65 | 5.60 | - | - |
Total Assets | 304.99 | 291.32 | 245.17 | 233.04 |
Accounts Payable | 128.94 | 127.33 | 109.66 | 110.34 |
Current Portof LT Debt/ Capital Leases | 28.13 | 33.36 | - | - |
Other Currentliabilities Total | 11.17 | 36.55 | 6.25 | 4.25 |
Total Current Liabilities | 168.24 | 168.14 | 130.08 | 132.61 |
Long Term Debt | 3.22 | 4.36 | - | - |
Total Long Term Debt | 3.22 | 4.36 | 0.00 | 0.00 |
Total Debt | 31.35 | 37.72 | 14.16 | 18.02 |
Deferred Income Tax | 0.75 | 1.42 | 1.46 | 1.56 |
Total Liabilities | 172.22 | 173.92 | 131.53 | 134.18 |
Common Stock Total | 28.05 | 25.38 | 25.38 | 23.38 |
Additional Paid- In Capital | 2.47 | 41.28 | - | - |
Retained Earnings( Accumulated Deficit) | 102.25 | 50.74 | 88.25 | 75.48 |
Total Equity | 132.77 | 117.41 | 113.64 | 98.86 |
Total Liabilities Shareholders' Equity | 304.99 | 291.32 | 245.17 | 233.04 |
Total Common Shares Outstanding | 2.81 | 2.54 | 2.54 | 2.34 |
Tangible Book Valueper Share Common Eq | 47.33 | 46.25 | 44.77 | 42.28 |
Prepaid Expenses | - | 2.46 | - | - |
Property/ Plant/ Equipment Total- Gross | - | 33.17 | - | - |
Accumulated Depreciation Total | - | -19.23 | - | - |
Accrued Expenses | - | -29.10 | - | - |
Notes Payable/ Short Term Debt | - | 0.00 | 14.16 | 18.02 |
Other Liabilities Total | - | 0.00 | 0.00 | - |
Capital Lease Obligations | - | - | - | 0.00 |
Aarey Drugs & Pharmaceuticals Dividend Aarey Drugs & Pharmaceuticals Bonus Aarey Drugs & Pharmaceuticals News Aarey Drugs & Pharmaceuticals AGM Aarey Drugs & Pharmaceuticals Rights Aarey Drugs & Pharmaceuticals Splits Aarey Drugs & Pharmaceuticals Board Meetings Aarey Drugs & Pharmaceuticals Key Metrics Aarey Drugs & Pharmaceuticals Shareholdings Aarey Drugs & Pharmaceuticals Profit Loss Aarey Drugs & Pharmaceuticals Cashflow Aarey Drugs & Pharmaceuticals Q1 Results Aarey Drugs & Pharmaceuticals Q2 Results Aarey Drugs & Pharmaceuticals Q3 Results Aarey Drugs & Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks